Kedudukan dalam Saham
#41692
Vaxxinity, Inc., a biotechnology company founded in 2014 and headquartered in... Vaxxinity, Inc., a biotechnology company founded in 2014 and headquartered in Dallas, Texas, is dedicated to advancing novel therapeutic candidates for human application in the United States. Its primary areas of focus are neurological disorders and infectious diseases, particularly those caused by coronaviruses. The company's pipeline features several key programs: UB-311 is a Phase 2 clinical trial candidate targeting toxic aggregated amyloid-beta proteins in the brain, aiming to treat Alzheimer's disease. UB-312, currently in Phase 1 clinical trials, is an investigational therapy designed to address Parkinson's disease and other synucleinopathies, including Lewy body dementia and multiple system atrophy, by targeting detrimental aggregated alpha-synuclein. An anti-tau product candidate is also under development for various neurodegenerative conditions, such as Alzheimer's disease. UB-313 is being developed to alleviate migraines by modulating calcitonin gene-related peptide. An anti-PCSK9 candidate aims to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events by targeting proprotein convertase subtilisin/kexin type 9 serine protease. In the infectious disease segment, UB-612 is a Phase 3 clinical-stage candidate engineered to neutralize the SARS-CoV-2 virus.
Harga Saham
$0.0001
Disegerakkan terakhir: 2026-08-11
Perubahan (1 tahun)
-99.76%
Perdagangan Vaxxinity, Inc. (VAXX)
Harga VAXX dengan permodalan pasaran b
Modal pasaran bagi Vaxxinity, Inc.(VAXX)
Modal Pasaran: $12.68K
Sehingga August 2026, Vaxxinity, Inc. mempunyai modal pasaran sebanyak $12.68K. Ini menjadikan Vaxxinity, Inc. syarikat ke-41692nd paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Vaxxinity, Inc. dari 2021 hingga 2026
VAXX berbanding dengan 5 teratas yang paling popular stocks
| Harga VAXX |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.383T
|
+42,462,213,656.11%
|
|
|
|
|
$4.423T
|
+34,890,291,773.62%
|
|
|
|
|
$4.160T
|
+32,815,660,091.53%
|
|
|
|
|
$3.663T
|
+28,895,100,365.37%
|
|
|
|
|
$2.891T
|
+22,805,085,839.42%
|
